The estimated Net Worth of Capital Management, Llc Aqu... is at least 20 百万$ dollars as of 22 September 2022. Capital Aqu owns over 1,901,796 units of Spero Therapeutics Inc stock worth over 4,582,043$ and over the last 4 years Capital sold SPRO stock worth over 15,413,713$.
Capital has made over 23 trades of the Spero Therapeutics Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently Capital sold 1,901,796 units of SPRO stock worth 4,279,041$ on 22 September 2022.
The largest trade Capital's ever made was selling 1,901,796 units of Spero Therapeutics Inc stock on 22 September 2022 worth over 4,279,041$. On average, Capital trades about 176,598 units every 30 days since 2020. As of 22 September 2022 Capital still owns at least 3,419,435 units of Spero Therapeutics Inc stock.
You can see the complete history of Capital Aqu stock trades at the bottom of the page.
Over the last 15 years, insiders at Spero Therapeutics Inc have traded over 15,920,732$ worth of Spero Therapeutics Inc stock and bought 3,223,281 units worth 44,767,755$ . The most active insiders traders include Plc Gsk、Jean Francois Formela、Capital Management, Llc Aqu.... On average, Spero Therapeutics Inc executives and independent directors trade stock every 71 days with the average trade being worth of 122,858$. The most recent stock trade was executed by Ankit Mahadevia on 27 August 2024, trading 5,912 units of SPRO stock currently worth 7,981$.
spero therapeutics is focused on the development of novel therapies to treat highly resistant bacterial infections. the culture at spero is one of respect, action, collaboration and transparency. spero team members are leaders in the field, and have the ability and desire to be a part of a team. at spero, a feeling that we are part of something groundbreaking and innovative fuels our approach.
Spero Therapeutics Inc executives and other stock owners filed with the SEC include: